Cited by 960Cancer-related Molecular PathwaysCancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.

p53 and metabolism

Vousden, Karen H., Ryan, Kevin M.·2009·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Although metabolic alterations have been observed in cancer for almost a century, only recently have the mechanisms underlying these changes been identified and the importance of metabolic transformation realized. p53 has been shown to respond to metabolic changes and to influence metabolic pathways through several mechanisms. The contributions of these activities to tumour suppression are complex and potentially rather surprising: some reflect the function of basal p53 levels that do not require overt activation and others might even promote, rather than inhibit, tumour progression.

Integrity signals

Registry

Crossref · 10.1038/nrc2715

Cites

134 of 134 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Tissue-specific Autophagy Alterations and Increased Tumorigenesis in Mice Deficient in Atg4C/Autophagin-3
Mariño, G., Salvador-Montoliu, N., Fueyo, A., Knecht, E., Mizushima, N., & López-Otı́n, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701194200 · Cited by 427
Retracted
On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Development by Self-Digestion
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,728
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citation
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452
p53 in health and disease
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,351
Self-citation

Flagged first, then by citations

Show all 134 references

Sorted by citations

Items 701–800 of 960

PTEN, energy metabolism and tumor suppression
Liu, J., & Feng, Z. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms048 · Cited by 11
Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner
Charni‐Natan, M., Solomon, H., Molchadsky, A., Jacob-Berger, A., Goldfinger, N., & Rotter, V. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0697-4 · Cited by 11
Noninvasive assessment and quantification of tumor vascularization using [18F]FDG-PET/CT and CE-CT in a tumor model with modifiable angiogenesis—an animal experimental prospective cohort study
Mirus, M., Tokalov, S. V., Abramyuk, A. M., Heinold, J., Prochnow, V., Zöphel, K., Kotzerke, J., & Abolmaali, N. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0502-0 · Cited by 11
eIF5B regulates the expression of PD-L1 in prostate cancer cells by interacting with Wig1
Li, Q., Xiao, M., Shi, Y., Hu, J., Bi, T., Wang, C., Yan, L., & Li, X. (2021) · BMC Cancer · doi:10.1186/s12885-021-08749-w · Cited by 11
Analysis of the p53/microRNA Network in Cancer
Kaller, M., Hünten, S., Siemens, H., & Hermeking, H. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-08356-3_7 · Cited by 12
Analysis of Transcriptional Factors and Regulation Networks in Laryngeal Squamous Cell Carcinoma Patients with Lymph Node Metastasis
Cai, G., Huang, D., Dai, Y., Liu, Y., Pi, L., Tan, H., Liu, L., Lv, Y., Yu, C.-Y., Tan, P., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200831g · Cited by 11
Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation
Micewicz, E. D., Sharma, S. K., Waring, A. J., Luong, H. T., McBride, W. H., & Ruchala, P. P. (2015) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-015-9487-3 · Cited by 11
Protective effect of p53 on the viability of intervertebral disc nucleus pulposus cells under low glucose condition
Xiong, X., Dai, L., Liang, W., Zhang, J., Qin, S., Cao, W., Ye, D., Liang, P., & Liu, Z. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.055 · Cited by 10
18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer
Vicente, A. M. G., Castrejón, Á. S., Calatayud, F. R., Madero, V. M., Garrido, M. J. M., Martín, A. A. L., García, J. M. C., Woll, J. P. P., López-Muñíz, I. C., & Muñoz, A. P. (2012) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2012.10.001 · Cited by 10
Metabolic Effect of Estrogen Receptor Agonists on Breast Cancer Cells in the Presence or Absence of Carbonic Anhydrase Inhibitors
Belkaid, A., Čuperlović‐Culf, M., Touaibia, M., Ouellette, R. J., & Surette, M. E. (2016) · Metabolites · doi:10.3390/metabo6020016 · Cited by 10
Lipidomic analysis of skeletal muscle tissues of p53 knockout mice by nUPLC-ESI-MS/MS
Park, S. M., Byeon, S. K., Lee, H., Sung, H., Kim, I. Y., Seong, J. K., & Moon, M. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-02065-9 · Cited by 10
Neonatal Exposure to 6-n-Propyl-Thiouracil, an Anti-Thyroid Drug, Alters Expression of Hepatic DNA Methyltransferases, Methyl CpG-Binding Proteins, Gadd45a, p53, and PCNA in Adult Male Rats
Bunker, S. K., Dandapat, J., Chainy, G. B. N., Sahoo, S. K., & Nayak, P. K. (2017) · European Thyroid Journal · doi:10.1159/000479681 · Cited by 10
Comparison of Modules of Wild Type and Mutant Huntingtin and TP53 Protein Interaction Networks: Implications in Biological Processes and Functions
Basu, M., Bhattacharyya, N. P., & Mohanty, P. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064838 · Cited by 10
Effects of deranged metabolism on epigenetic changes in cancer
Chandra, V., & Hong, K. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0561-3 · Cited by 11
Transcriptional Regulation of the Human Genes that Encode DNA Repair- and Mitochondrial Function-Associated Proteins
Uchiumi, F., Larsen, S. H., & Tanuma, S. (2015) · InTech eBooks · doi:10.5772/59588 · Cited by 10
Lysine Deprivation Induces AKT-AADAT Signaling and Overcomes EGFR-TKIs Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells
Hsu, C., Yang, A. Y.-P., Chen, J.-Y., Tsai, H.-H., Lin, S.-H., Tai, P.-C., Huang, M.-H., Hsu, W.-H., Lin, A. M.-Y., & Yang, J. C. (2021) · Cancers · doi:10.3390/cancers13020272 · Cited by 10
Immunological and Genetic Characterization of Patients With Head and Neck Cancer who Developed Recurrence
Yasui, K., Kondou, R., Miyata, H., Iizuka, A., Ashizawa, T., Nagashima, T., Ohshima, K., Urakami, K., Muramatsu, K., Sugino, T., et al. (2022) · Anticancer Research · doi:10.21873/anticanres.15942 · Cited by 10
Unlocking mitochondrial dysfunction-associated senescence (MiDAS) with NAD+ – A Boolean model of mitochondrial dynamics and cell cycle control
Sizek, H., Deritei, D., Fleig, K., Harris, M., Regan, P., Glass, K., & Regan, E. R. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102084 · Cited by 9
Inference of cancer mechanisms through computational systems analysis
Qi, Z., & Voit, E. O. (2017) · Molecular BioSystems · doi:10.1039/c6mb00672h · Cited by 9
p63 orchestrates serine and one carbon metabolism enzymes expression in head and neck cancer
Cappello, A., Tosetti, G., Smirnov, A., Ganini, C., Yang, X. F., Shi, Y., Wang, Y., Melino, G., Bernassola, F., & Candi, E. (2023) · Biology Direct · doi:10.1186/s13062-023-00426-1 · Cited by 9
Cancer-specific Therapeutic Potential of Resveratrol: Metabolic Approach against Hallmarks of Cancer
Suh, D. H., Kim, M., Kim, H. S., Chung, H. H., & Song, Y. S. (2013) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v3i8.44 · Cited by 9
p53 Mediates impaired insulin signaling in 3T3‐L1 adipocytes during hyperinsulinemia
kumari, P. J., Selvaraju, S., Sangeetha, K. N., Baskaran, S. K., & Lakshmi, B. S. (2014) · Cell Biology International · doi:10.1002/cbin.10275 · Cited by 9
Overexpression of p53 Improves Blood Glucose Control in an Insulin Resistant Diabetic Mouse Model
Zhang, X., Duan, W., Lee, W. P., Zhang, Y., Xiang, F., Liu, Q., Go, V. L. W., & Xiao, G. G. (2016) · Pancreas · doi:10.1097/mpa.0000000000000637 · Cited by 9
Spatial profiles of markers of glycolysis, mitochondria, and proton pumps in a rat glioma suggest coordinated programming for proliferation
Grillon, E., Farion, R., Reuveni, M., Glidle, A., Rémy, C., & Coles, J. A. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1191-z · Cited by 9
P53‐Mediated Repression of the Reprogramming in Cloned Bovine Embryos Through Direct Interaction with HDAC 1 and Indirect Interaction with DNMT 3A
Ma, P., Zhang, H., Li, R., Wang, Y., Zhang, Y., & Hua, S. (2015) · Reproduction in Domestic Animals · doi:10.1111/rda.12502 · Cited by 9
Cancer Cell Metabolism
Patnaik, A., Locasale, J. W., & Cantley, L. C. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0598-6_13 · Cited by 9
Crocodile blood extract induces the apoptosis of lung cancer cells through PTEN activity
Ou, Y., & Ho, W. S. (2016) · Oncology Reports · doi:10.3892/or.2016.4914 · Cited by 9
Molecular characterization, expression, and H2O2 induction of p53 and mdm2 in the ricefield eel, Monopterus albus
He, Z., Deng, F., Ma, Z., Zhang, Q., He, J., Ye, L., Chen, H., Yang, D., He, L., Luo, J., et al. (2021) · Aquaculture Reports · doi:10.1016/j.aqrep.2021.100675 · Cited by 9
Mosaic gastruloids reveal a temporal restriction for developmental cell competition
Frenster, J. D., Babin, S., Casani-Galdon, P., Josende-Garcia, J. B., Pascual-Mas, P., Robertson, G., Edri, S., Wehmeyer, A. E., Arnold, S. J., García‐Ojalvo, J., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01923-x · Cited by 8
Metabolic stress regulates genome-wide transcription in a PTEN-dependent manner
Abbas, A., Padmanabhan, R., & Eng, C. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa168 · Cited by 8
Doxorubicin Attenuates Free Fatty Acid-Induced Lipid Accumulation via Stimulation of p53 in HepG2 Cells
Yun, C., Kim, S. H., Kwon, D., Byun, M. R., Chung, K. W., Lee, J., & Jung, Y. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.200 · Cited by 8
FUCA1: An Underexplored p53 Target Gene Linking Glycosylation and Cancer Progression
Hu, D., Kobayashi, N., & Ohki, R. (2024) · Cancers · doi:10.3390/cancers16152753 · Cited by 8
Antioxidant Role of p53 and of Its Target TP53INP1
Seillier, M., Peuget, S., Dusetti, N., & Carrier, A. (2012) · InTech eBooks · doi:10.5772/50790 · Cited by 9
The p53 family member p73 modulates the proproliferative role of IGFBP3 in short children born small for gestational age
Marzano, F., Ventura, A., Caratozzolo, M. F., Aiello, I., Mastropasqua, F., Brunetti, G., Cavallo, L., Sbisà, E., Faienza, M. F., & Tullo, A. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-02-0105 · Cited by 8
Total Synthesis of the Antitumor Depsipeptide FE399 and Its S‐Benzyl Derivative: A Macrolactamization Approach
Tonoi, T., Ikeda, M., Sato, T., Inohana, T., Kawahara, R., Murata, T., & Shiina, I. (2020) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202000459 · Cited by 8
Clinical and prognostic implications of an immune‐related risk model based on TP53 status in lung adenocarcinoma
Song, X., Chen, Q., Wang, J., Mao, Q., Xia, W., Xu, L., Jiang, F., & Dong, G. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17097 · Cited by 8
SUMO1 Promotes Mesangial Cell Proliferation Through Inhibiting Autophagy in a Cell Model of IgA Nephropathy
Tan, X., Liu, Y., Liu, D., Tang, X., Xia, M. X., Chen, G., He, L., Zhu, X., & Liu, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.834164 · Cited by 8
A Narrative Review of the TP53 and Its Product the p53 Protein
Foroutan, B. (2023) · OBM Genetics · doi:10.21926/obm.genet.2302185 · Cited by 8
Effects of leucine on mitochondrial biogenesis and cell cycle in A‐375 melanoma cells
Filhiol, T. M., Johnstone, M. E., & Zemel, M. B. (2012) · The FASEB Journal · doi:10.1096/fasebj.26.1_supplement.363.4 · Cited by 8
The effect of endurance training with and without vitamin E on expression of p53 and PTEN tumor suppressing genes in prostate glands of male rats
Dashtiyan, A. A., Sepehrimanesh, M., Tanideh, N., & Afzalpour, M. E. (2017) · Biochimie Open · doi:10.1016/j.biopen.2017.03.005 · Cited by 8
p53 is required for brain growth but is dispensable for resistance to nutrient restriction during Drosophila larval development
Contreras, E. G., Sierralta, J. A., & Glavic, Á. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194344 · Cited by 8
Regulatory role of TIGAR on endothelial metabolism and angiogenesis
He, X., Zeng, H., Cantrell, A. C., & Chen, J. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30401 · Cited by 8
Regulation of cancer cell metabolism
Gao, P., & Wei, H. (2017) · Scientia Sinica Vitae · doi:10.1360/n052016-00334 · Cited by 8
Breath-based lung cancer detection using an ML-driven low-cost sensor array
Iyer, D., Gobinath, K., Kowkuntla, K., Wanjari, V. V., & Banumurthy, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-26416-z · Cited by 7
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma
Dunsche, L., Ivanisenko, N. V., Riemann, S., Schindler, S., Beissert, S., Angeli, C., Kreis, S., Tavassoli, M., Lavrik, I. N., & Kulms, D. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06360-4 · Cited by 7
Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growthin vivo
Jung, C. L., Mun, H., Jo, S., Oh, J., Lee, C., Choi, E., Jang, S. J., & Suh, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12758 · Cited by 7
Refractory Lactic Acidosis and an Approach to Its Management - A Case Report
He, Y., Ong, J., & Ong, S. G. K. (2018) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2019-0010 · Cited by 7
p53-Mediated Indirect Regulation on Cellular Metabolism: From the Mechanism of Pathogenesis to the Development of Cancer Therapeutics
Wang, C.-Y., & Chao, C.-H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.895112 · Cited by 7
Tumor suppressive pathways in the control of neurogenesis
Bartesaghi, S., & Salomoni, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1063-9 · Cited by 8
Association of the Arg72Pro Polymorphism in p53 with Progression of Diabetic Nephropathy in T2DM Subjects
Kaňková, K. (2014) · Journal of Nephrology & Therapeutics · doi:10.4172/2161-0959.1000153 · Cited by 7
CK2 induced RIG-I drives metabolic adaptations in IFNγ-treated glioma cells
Ghildiyal, R., & Sen, E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.10.009 · Cited by 7
AKT-p53 axis protect cancer cells from autophagic cell death during nutrition deprivation
Selvaraju, S., Sathya, S., Gokulapriya, G., & Lakshmi, B. S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.064 · Cited by 7
An AMPK-dependent, non-canonical p53 pathway plays a key role in adipocyte metabolic reprogramming
Wang, H., Wan, X., Pilch, P. F., Ellisen, L. W., Fried, S. K., & Liu, L. (2020) · eLife · doi:10.7554/elife.63665 · Cited by 7
BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer
Sólyom, S. (2011) · Cited by 7
p53, DNA damage, and NAD+ homeostasis
Pfister, N. T., Yoh, K. E., & Prives, C. L. (2014) · Cell Cycle · doi:10.4161/cc.29151 · Cited by 7
Guanine nucleotides drive ribosome biogenesis and glycolytic reprogramming in acute myeloid leukemia stem cells
Kawano, G., Ikeda, R., Ishihara, D., Shima, T., Sakoda, T., Yamamoto, S., Kochi, Y., Semba, Y., Ashitani, S., Mori, Y., et al. (2025) · Blood · doi:10.1182/blood.2025030209 · Cited by 6
Prognosis-related metabolic genes in the development of colorectal cancer progress and perspective
Miao, Y., Quan, W., Dong, X., Gan, J., Ji, C.-F., Wang, J., & Zhang, F. (2023) · Gene · doi:10.1016/j.gene.2023.147263 · Cited by 6
Unveiling OSCP as the potential therapeutic target for mitochondrial dysfunction-related diseases
Zhang, M., Luo, X., Zhang, B., Luo, D., Huang, L.-Z., & Long, Q. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122293 · Cited by 7
Skeletal muscle p53‐depletion uncovers a mechanism of fuel usage suppression that enables efficient energy conservation
Lenihan-Geels, G. N., García‐Carrizo, F., Leer, M., Gohlke, S., Oster, M., Pöhle‐Kronawitter, S., Ott, C., Chadt, A., Reinisch, I., Galhuber, M., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13529 · Cited by 6
A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer
Zhang, B., Zhang, H., & Qin, Y. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl25447 · Cited by 6
Pathway metabolite ratios reveal distinctive glutamine metabolism in a subset of proliferating cells
Santiappillai, N. T., Cao, Y., Hakeem-Sanni, M. F., Yang, J. Y. H., Quek, L., & Hoy, A. J. (2025) · Molecular Systems Biology · doi:10.1038/s44320-025-00099-0 · Cited by 6
The African-centric P47S Variant of TP53 Confers Immune Dysregulation and Impaired Response to Immune Checkpoint Inhibition
Stieg, D. C., Parris, J. L. D., Yang, T. H. L., Mirji, G., Reiser, S. K., Murali, N., Werts, M., Barnoud, T., Lu, D. Y., Shinde, R. S., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0149 · Cited by 6
UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma
Zhou, K., Wang, D., Du, X., Feng, X., Zhu, X., & Wang, C. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024033 · Cited by 6
Protéger et sévir : p53, métabolisme et suppression tumorale
Albagli, O. (2015) · médecine/sciences · doi:10.1051/medsci/20153110013 · Cited by 8
An analysis of the polymorphisms of the GLUT1 gene in urothelial cell carcinomas of the bladder and its correlation with p53, Ki67 and GLUT1 expressions
Xu, C., Yang, X., Wang, Y., Ding, N., Han, R., Sun, Y., & Wang, Y. (2017) · Cancer Gene Therapy · doi:10.1038/cgt.2017.17 · Cited by 6
Point of care breath analysis systems
Amal, H., & Haick, H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814827-3.00014-1 · Cited by 6
Identification of transcription factors MYC and C/EBPβ mediated regulatory networks in heart failure based on gene expression omnibus datasets
Wang, H., Wang, X., Xu, L., & Cao, H. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01527-9 · Cited by 7
Recombinant Adenoviral-p53 Agent (Gendicine®)
Zhang, S.-Y., Lu, Y., & Peng, Z. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-397833-2.00010-8 · Cited by 6
Bioinformatic analysis and experimental validation of six cuproptosis-associated genes as a prognostic signature of breast cancer
Chen, X., Sun, H., Yang, C., Wang, W., Lyu, W., Zou, K., Zhang, F., Dai, Z., 董, 华., & He, X. (2024) · PeerJ · doi:10.7717/peerj.17419 · Cited by 5
In vitro and in silico study of the synergistic anticancer effect of alpinumisoflavone with gemcitabine on pancreatic ductal adenocarcinoma through suppression of ribonucleotide reductase subunit-M1
Lee, W., Song, G., & Bae, H. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106969 · Cited by 5
Age-related differences in gene expression and pathway activation following heatstroke
Gomez, M., Mahri, S. A., Abdullah, M. L., Malik, S. S., Yezli, S., Yassin, Y. M., Khan, A. A., Lehé, C. L., Mohammad, S., Hoehndorf, R., et al. (2024) · Physiological Genomics · doi:10.1152/physiolgenomics.00053.2024 · Cited by 5
Gut microbes and their metabolites in relation to the classic tumor suppressor gene P53: a novel narrative
Li, J.-X., Liu, C., & Chen, J. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00775-x · Cited by 5
Comparative Transcriptome Profiling of an SV40-Transformed Human Fibroblast (MRC5CVI) and Its Untransformed Counterpart (MRC-5) in Response to UVB Irradiation
Chang, C.-W., Chen, C.-R., Huang, C.-Y., Shu, W., Chiang, C., Hong, J., & Hsu, I. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073311 · Cited by 5
Ablation of AMPK-Related Kinase MPK38/MELK Leads to Male-Specific Obesity in Aged Mature Adult Mice
Seong, H., & Ha, H. (2020) · Diabetes · doi:10.2337/db20-0436 · Cited by 5
p53-Bad* Fusion Gene Therapy Induces Apoptosis In Vitro and Reduces Zebrafish Tumor Burden in Hepatocellular Carcinoma
Bowman, K. E. R., Ahne, L., O’Brien, L., Mause, E. R. V., Lu, P., Wallis, B., Evason, K. J., & Lim, C. S. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00665 · Cited by 5
The spectrum of cell death in sarcoma
Belyaeva, E. D., Loginova, N., Schroeder, B., Goldlust, I. S., Acharya, A., Kumar, S., Timashev, P. S., & Ulasov, I. V. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114683 · Cited by 5
Hirocidins, Cytotoxic Metabolites from Streptomyces hiroshimensis , Induce Mitochondrion‐Mediated Apoptosis
Han, E. J., Jeong, M., Lee, S. R., Sorensen, E. J., & Seyedsayamdost, M. R. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202405367 · Cited by 5
Progress and bottleneck in induced pluripotency
Zhang, Z., & Xu, Y. (2012) · Cell Regeneration · doi:10.1186/2045-9769-1-5 · Cited by 5
Examining the connectivity between different cellular processes in the Barrett tissue microenvironment
Phelan, J. J., Feighery, R., Eldin, O. S., Meachair, S. O., Cannon, A., Byrne, R., MacCarthy, F., O’Toole, D., Reynolds, J. V., & O'Sullivan, J. N. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.041 · Cited by 5
Pathophysiology of Cancer Cell Death
Galluzzi, L., Linkermann, A., Kepp, O., & Kroemer, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00005-0 · Cited by 6
Induced pluripotent stem cell (iPS) technology: promises and challenges
Esteban, M. A., Gan, Y., Qin, D., & Pei, D. (2009) · Chinese Science Bulletin · doi:10.1007/s11434-009-0014-9 · Cited by 5
TP53 Gene Polymorphisms in Cancer Risk: The Modulating Effect of Ageing, Ethnicity and TP53 Somatic Abnormalities
Denisov, E. V., Nadezhda, V., Nicolay, V., Elena, A., Natalya, N. N., Valentina, A., & Mikhail, I. S. (2012) · InTech eBooks · doi:10.5772/27768 · Cited by 5
p53: An Immune Ecosystem Manipulator
Nian, Z., Dou, Y., & Wei, H. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-3628 · Cited by 4
Tumour Biology: p53 Gene Mechanisms
Zulfin Shaikh Niranjan, K. C. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000344 · Cited by 4
The MDM2/MDMX/p53 axis in the adaptive stress response
Wang, B., Rasmussen-Ivey, C. R., Little, J. B., & Yuan, Z.-M. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.12.89 · Cited by 4
Evaluation of Sestrin 2, Adiponectin, AMPK, and mTOR Genes Expression in Acute Myeloid Leukemia Patients.
Abtahi, S.-H., Mohammadi, M. H., Farsani, M. A., Aghelan, Z., & Salari, S. (2021) · PubMed Central · doi:10.30498/ijb.2021.2860 · Cited by 4
Glycolytic flux occurs in Drosophila melanogaster recovering from camptothecin treatment
Hull, R., & Ntwasa, M. M. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833e2f60 · Cited by 4
Metabolic permissiveness: how tissue context shapes cancerPreprint
Moschandrea, C., & Frezza, C. (2026) · Genes & Development · doi:10.1101/gad.353516.125 · Cited by 4
Unlocking the mitochondrial functional code: unraveling the pathogenesis of ovarian cancer and innovative targets to inhibit malignant behavior
Li, C.-Y., Ding, D., Guo, Y., Fu, Y., Shen, Y., Fu, J., Zhang, C.-X., & Han, F. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06840-5 · Cited by 3
Mitochondrially Targeted p53-Bad* Fusion Gene Therapy Promotes Apoptosis in Hepatocellular Carcinoma by Pan-Bcl-2 Inhibition
Hornsby, B. D., Tuekpe, J. K. K., Steele, C. A., Devereaux, A. A., Bowman, K. E. R., & Lim, C. S. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00773 · Cited by 3
Mutant p53 Regulates Pyruvate Dehydrogenase Kinase 1 ( PDK1 ) to Promote Proliferation and Migration in Breast Cancer
Ye, Y., Ou, Z., Li, C., Liao, Q., Zeng, Q., Ju, X., Zhang, D., Wei, Y., Zhang, X., Zhang, J., et al. (2025) · Cancer Science · doi:10.1111/cas.70252 · Cited by 3
Development and validation of an interpretable machine learning model for predicting progression-free survival after immunotherapy in patients with non-small cell lung cancer: a multicenter study
Li, Y., Ji, X., He, T., Hu, Y., Zhou, D., Zou, D., Li, B., Zhang, M., Huang, Z., Zhang, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1686260 · Cited by 3
Monitoring early micro-oxidation under refrigeration: iron and oxidative markers predict quality loss in grass carp
Xiong, X., Feng, R., Zhang, H., Ding, N., Zhuang, S., Tan, Y., Ma, H., Hong, H., & Luo, Y. (2026) · Current Research in Food Science · doi:10.1016/j.crfs.2026.101307 · Cited by 3
Cancer Drug Resistance and Metabolic Reprogramming
Jan, S., Fatima, K., Wani, A., Malik, F. A., & Khan, S. U. (2024) · Springer eBooks · doi:10.1007/978-981-97-1666-1_6 · Cited by 3
Halogenated Boroxine K2[B3O3F4OH] Modulates Metabolic Phenotype and Autophagy in Human Bladder Carcinoma 5637 Cell Line
Elez-Burnjaković, N., Pojskić, L., Haverić, A., Lojo-Kadrić, N., Hadžić, M., Smajlović, A., Kalaydjiev, S., Maksimović, M., Joksimović, B., & Haverić, S. (2024) · Molecules · doi:10.3390/molecules29122919 · Cited by 3
FABP4 deficiency ameliorates alcoholic steatohepatitis in mice via inhibition of p53 signaling pathway
Xing, H., Wu, Z. H., Jiang, K., Yuan, G., Guo, Z., Yu, S., He, S., & Zhong, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-71311-8 · Cited by 3
Repressors of reprogramming
Popowski, M. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i3.541 · Cited by 3
Influence of Tumor Suppressor p53 Functioning on the Expression of Antioxidant System Genes under the Action of Cytotoxic Compounds
Mumyatova, V. A., Балакина, А. А., Лапшина, М. А., Sen', V. D., Kornev, A. B., & Терентьев, А. А. (2020) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-020-04844-3 · Cited by 3
p53 and cancer metabolism
ZHANG, X.-H., & Le, L. I. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2022-0009 · Cited by 3
Metabolic signature and response to glutamine deprivation are independent of p53 status in B cell malignancies
Montironi, C., Chen, Z., Derks, I. A. M., Cretenet, G., Krap, E. A., Eldering, E., & Simon‐Molas, H. (2024) · iScience · doi:10.1016/j.isci.2024.109640 · Cited by 3

Authors: Vousden, K. H., & Ryan, K. M.
Affiliations: Cancer Research UK Scotland Institute (GB)
ORCID: Vousden, Karen H.
Ryan, Kevin M.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2009-09-17
Volume: 9
Issue: 10
Pages: 691-700
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2715
OpenAlex: W1991510903
Cited by: 959
References: 134
Citations by year: 2026: 23 · 2025: 39 · 2024: 37 · 2023: 36 · 2022: 49 · 2021: 46 · 2020: 44 · 2019: 39 · 2018: 49 · 2017: 52 · 2016: 60 · 2015: 78 · 2014: 84 · 2013: 97 · 2012: 82
FWCI: 6.60
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Funders: Cancer Research UK
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: p53, cancer metabolism, tumor suppression, tumor progression, metabolic pathways, cancer cells
MeSH terms: Autophagy, Cell Transformation, Neoplastic, Glycolysis, Humans, Neoplasms, Tumor Suppressor Protein p53, Oxidative Stress, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

p53 and metabolism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks